Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new press release entry 'Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas' dated 08 Dec 2025 was added, bringing the total results to 483. Several older press release entries were removed from the list.
    Difference
    3%
    Check dated 2025-12-08T23:19:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new press release entry 'Genentech’s Giredestrant Becomes the First Oral SERD to Show Superior Invasive Disease-Free Survival in Early Breast Cancer' (17 Nov 2025) has been added, increasing the total results to 482. The previously listed entry 'Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types' (12 Oct 2025) has been removed.
    Difference
    0.8%
    Check dated 2025-11-24T14:34:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A new press release titled 'Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis' (dated 09 Nov 2025) was added, bringing the total results to 481. The older release 'FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer' (dated 02 Oct 2025) was removed.
    Difference
    0.8%
    Check dated 2025-11-17T06:51:46.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Two new press releases appear in the listing (Gazyva Phase III data for lupus; ASH 2025 data). The total results count increases from 478 to 480, and older items such as Ocrevus/Fenebrutinib at ECTRIMS and Giredestrant Phase III data are removed.
    Difference
    1%
    Check dated 2025-11-10T04:53:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new press release titled 'Positive Phase III Results for Genentech’s Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome' (27 Oct 2025) was added. The entry 'New Data for Genentech’s Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)' (04 Sep 2025) was removed, and the total results now show 478.
    Difference
    0.8%
    Check dated 2025-11-03T01:18:35.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Page now features new high-importance Genentech press releases and 2025 dates, including Phase III data and new launches; older, lower-importance updates have been removed to emphasize current news.
    Difference
    70%
    Check dated 2025-10-19T16:34:43.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.